Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional survey.

about

Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional survey.

Item

http://www.wikidata.org/entity/Q38837339

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Diagnosis and treatment of mul ...... de multi-institutional survey.

@en

type

Item

label

Diagnosis and treatment of mul ...... de multi-institutional survey.

@en

prefLabel

Diagnosis and treatment of mul ...... de multi-institutional survey.

@en

P1476

Diagnosis and treatment of mul ...... de multi-institutional survey.

@en

P2093

Hans-Joachim Tischler

http://www.w3.org/2001/XMLSchema#string

Joern Kohnke

http://www.w3.org/2001/XMLSchema#string

Lenka Kellermann

http://www.w3.org/2001/XMLSchema#string

Maximilian Merz

http://www.w3.org/2001/XMLSchema#string

Wolfgang Knauf

http://www.w3.org/2001/XMLSchema#string

Wolfram Poenisch

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-l

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transpla

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

Treatment options for relapsed and refractory multiple myeloma.

Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.

P304

987-993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-017-2991-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hartmut Goldschmidt

P577

2017-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28409228

http://www.w3.org/2001/XMLSchema#string

P921

A' Ghearmailt